Tesamorelin is a structurally modified GHRH analog engineered for enhanced stability and prolonged receptor interaction
About orforglipron Orforglipron (or-for-GLIP-ron) is an investigational, once-daily small molecule (non-peptide) oral glucagon-like peptide-1 receptor agonist that can be taken any time of the day without restrictions on food and water intake
ALCAR, in particular, has been shown to stabilize cardiolipin, the crucial lipid that anchors the mitochondrial membrane
Patients specifically seeking compounded GLP-1 access need to evaluate telehealth platforms that facilitate compounded medication prescribing through licensed compounding pharmacies, such as Direct Meds
Tranexamic acid (topical): Investigated in clinical trials for melasma with more robust evidence than IV glutathione
The goal is sustainable, medically supported weight loss and better health over time